Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q4 2021 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's size, with disproportionate scale relative to smallness. Look for statements about current activity, demand, commitments, volumes, etc., that are large relative to the company's size. In the transcript, Matt Oppenheimer says: "we are winning market share with 50% active customer growth in an overall remittance market that is growing in the single-digit." That indicates growth but not necessarily disproportion relative to company size. He also says "we have approximately 1% of the overall market" and "we've got a market that's rapidly shifting digital and a clear ROI for capturing that shift." That suggests they are small relative to market, but is that about current activity? They mention "we are just getting started" and "it's never felt more like this than today." But is that about current business arriving at scale? They talk about expanding corridors, new products, but those are future. They mention "Remitly for developers" with Coinbase partnership, but that's a partnership, not necessarily large relative to company. The key is whether management describes current activity that is disproportionately large compared to the company's size. They mention 50% active customer growth, but that's growth, not necessarily a disproportion. They also mention "we have approximately 1% of the overall market" - that indicates small market share, but the question is about what is arriving now. They say "we are winning market share" - that's current. But is that "disproportionately large" relative to their size? They are small, but the growth is high. However, the question asks for a coherent situation where the company is small and what is happening now is large relative to that smallness. For example, a single contract that could rival the company's size. There's no such specific mention. They talk about "tens of thousands of customers per week" for sideline rates, but that's about reducing sideline rates, not about scale. They also say "our business outside the U.S. delivered $120 million in revenue in 2021, up from $58 million in 2020. Yet it was only 26% of total revenue in 2021." That's about growth but not disproportion. The question is strict: "management's own words convey...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.